Health Condition 1: E785- Hyperlipidemia, unspecified
Conditions
Interventions
None listed
Sponsors
All India Institute Of Ayurveda
Eligibility
Inclusion criteria
Inclusion criteria: Patient Fulfilling The Diagnostic Criteria Of Dyslipidemia Serum Triglyceride 150-250 mg/dl Or Serum Cholesterol 200-239 mg/dl Or Serum LDL Cholesterol 130-159 mg/dl Or Serum HDL Cholesterol Male Less than 40 mg/dl Female Less than 50 mg/dl
Exclusion criteria
Exclusion criteria: 1 Patients With Uncontrolled Diabetes Mellitus (Hba1c More Than 9%) 2 Uncontrolled Hypothyroidism (TSH More Than 10 mIU/L) 3 Patients With Severe Cardiovascular Disease Like MI CAD Cardiac Failure Any Other Life Threatening Condition 4 History Of Hypersensitivity To Any Of The Trial Drugs Or Their Ingredients 5 Pregnancy And Lactating Women 6 Any Other Conditions /Medications Which Can Interfere With Interventions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 50% Reduction In Raise Abnormal Lipid Level 1 Serum Cholesterol Reduction From 239 To 220 mg/dl 2 Serum Triglyceride Reduction From 250 To 200 mg/dl 3 Serum LDL Cholesterol Reduction From 159 To 145 mg/dl Timepoint: Day 0 And Day 45 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1 Changes In The Signs And Symptoms Of Medoroga 2 Overall Improvement In Quality Of Life 3 Safety Assessment Of The Trial Drug Timepoint: Day 0 And Day 45 | — |
Countries
India
Contacts
Public ContactDr Ayesha Julka
All India Institute Of Ayurveda
Outcome results
None listed